Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CryptoT&T cryptosporidiosis point-of-care test-and-treat trial in young children with diarrhoea
PACTR202608674781580Phase 4Not yet recruiting
- Sponsor
- Armauer Hansen Research Institute
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of nitazoxanide in cryptosporidiosis (2 arms), sponsored by Armauer Hansen Research Institute. Primary endpoint: Diarrhea duration. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nitazoxanide
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on PACTR202608674781580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608674781580.